Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales ...

Sanofi has reported that the high-dose formulation of its influenza vaccine, Elfueda (known as Fluzone High-Dose in the US), ...

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects ...

Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...

International Patient Engagement Day 2025 has been launched by the International Society for Patient Engagement Professionals ...

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

Healthcare research with the potential to improve patient outcomes is abundant; however, evidence often fails to be promptly ...

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern ...

Bristol Myers Squibb (BMS) has agreed to acquire Orbital Therapeutics in a deal valued at $1.5bn. Robert Plenge, executive VP ...